A meeting was held in Bishkek, organized as part of the mission of international experts from the UN Industrial Development Organization (UNIDO). Participants included representatives from the Ministry of Economy, the Ministry of Health, and local pharmaceutical companies, as reported by the press service of the Ministry of Economy of the Kyrgyz Republic.
During the meeting, issues related to the development of the pharmaceutical industry were raised, discussing the requirements of the Eurasian Economic Union for GMP standards and mechanisms to support the modernization of production in the pharmaceutical sector.
A seminar titled "Strengthening Compliance of the Pharmaceutical Industry of the Kyrgyz Republic with Good Manufacturing Practice Requirements: Assessment Results, International Standards, and Next Steps" also took place, with participation from representatives of government agencies, pharmaceutical producers, and international experts.
UNIDO experts shared the results of the assessment of domestic pharmaceutical enterprises' compliance with GMP standards and discussed international standards and regulatory practices in this area.
Particular attention was paid to the implementation of GMP standards as an important step towards improving the quality and safety of medications, as well as expanding the export opportunities of Kyrgyz producers in the markets of the Eurasian Economic Union countries.
Participants were also presented with the results of a survey conducted by UNIDO among pharmaceutical manufacturers, aimed at determining the current level of readiness for the implementation of GMP standards and identifying key areas necessary for further development and modernization of production processes.
As part of the mission, UNIDO experts planned technical visits to pharmaceutical enterprises in the country to assess the level of GMP standards implementation and identify needs for technical and expert support.
The implementation of these initiatives is expected to lead to an increase in the quality and safety of medical products, the development of the national pharmaceutical industry, and an increase in the export potential of local producers.
